Recently it was shown that the dystrophin–glycoprotein complex interacts with the insulin receptor and regulates insulin signalling in skeletal muscle (43), suggesting that mutations in this complex contribute to the development of insulin resistance and T2D. The gene discussed is DMD; the disease is Insulin resistance.